You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute Lymphoblastic Leukemia (ALL) Philadelphia chromosome positive

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

Not yet recruiting
  • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
  • Inotuzumab Ozogamicin
  • (no location specified)
Nov 3, 2022

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Bordeaux, Aquitaine, France
  • +11 more
Dec 6, 2020

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 25, 2023

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 10, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • QH103 Cell Injection
  • +2 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Sep 21, 2023

Infective Complications and Outcome of ALL Treated With INO

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
    • (no location specified)
    Aug 29, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Leukemia, Lymphoblastic, Acute, Philadelphia-Positive Trial in Valencia (dasatinib)

    Completed
    • Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    • Valencia, Spain
      Hospital La Fe
    Mar 16, 2022

    Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +21 more
    • Birmingham, Alabama
    • +219 more
    Sep 15, 2022

    Next-generation Sequencing in Pediatric B-ALL Children Patients

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • (no location specified)
    Apr 19, 2023

    Vaccine Immune Recovery After Leukemia

    Enrolling by invitation
    • Acute Lymphoblastic Leukemia, Pediatric
    • Observational only
    • Chicago, Illinois
    • +2 more
    Nov 9, 2022

    B-cell Acute Lymphoblastic Leukemia, B Lineage Lymphoblastic Lymphoma Trial in Philadelphia (Autologous, humanized anti-CD22 CAR

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B Lineage Lymphoblastic Lymphoma
    • Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
    • Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Jan 25, 2023

    Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

    Completed
    • Acute Lymphoblastic Leukemia
      • Brno, Czechia
      • +9 more
      Sep 12, 2022

      Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 2, 2023

      Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

      Recruiting
      • Neoplasms
      • +2 more
      • RD13-02 cell infusion
      • Xuzhou, Jiangsu, China
        Affiliated hospital of Xuzhou medical college
      Jun 7, 2023

      Acute Lymphoblastic Leukemia Trial in Hangzhou (Blinatumomab)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Nov 5, 2023

      B Cell Acute Lymphoblastic Leukemia (B-ALL), B Lineage Lymphoblastic Lymphoma Trial (Autologous Humanized CD19-Directed Chimeric

      Not yet recruiting
      • B Cell Acute Lymphoblastic Leukemia (B-ALL)
      • B Lineage Lymphoblastic Lymphoma
      • Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
      • (no location specified)
      Jul 27, 2022

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 24, 2022

      Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia

      Completed
      • Childhood Acute Lymphoblastic Leukemia in Remission
      • Recurrent Childhood Acute Lymphoblastic Leukemia
      • Laboratory Biomarker Analysis
      • Philadelphia, Pennsylvania
        Childrens Oncology Group
      Aug 12, 2022

      B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • single dose of CNCT19
      • (no location specified)
      Dec 19, 2022

      Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +2 more
      • Low-field magnetic resonance imaging
      • +3 more
      • Erlangen, Bavaria, Germany
        Department of Pediatrics and Adolescent Medicine
      Oct 23, 2023

      T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma Trial in Barcelona (CD1a-CAR T)

      Not yet recruiting
      • T-cell Acute Lymphoblastic Leukemia
      • Lymphoblastic T-Cell Lymphoma
      • CD1a-CAR T
      • Barcelona, Spain
      • +1 more
      Jan 10, 2023

      B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

      Withdrawn
      • B-cell Acute Lymphoblastic Leukemia
      • B-ALL
      • U-CAR-T Cells (LstCAR019)
      • Kunming, Yunnan, China
        Kunming Hope of Health Hospital
      Nov 27, 2022

      Acute Lymphoblastic Leukemia, Obesity Trial in New York (PEDALL, Standard of care)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Obesity
      • PEDALL
      • Standard of care
      • New York, New York
        Columbia University Medical Center
      Jul 19, 2023